Anti-GPC3-CAR Autologous T Lymphocytes
SUSPENDED · PHASE1 · Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Refractory Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8
awaiting agreement with Sponsor
Registry sourceScientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.
Detailed evidence is available in the local Pro plan simulation.